Curanex Pharmaceuticals Inc. (CURX) Financial Statements

52 Followers

Curanex Pharmaceuticals Inc. Financial Overview

Curanex Pharmaceuticals Inc.'s market cap is currently $13.34M. The company's EPS TTM is $; its P/E ratio is -2.00; Curanex Pharmaceuticals Inc. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ 0.00	$ 0.00	$ 0.00
Operating Income	$ -4.24M	$ -365.06K	$ -19.30K
EBITDA	$ -4.24M	$ -290.39K	$ -17.48K
Net Income	$ -4.23M	$ -361.51K	$ -19.20K
Balance Sheet
Cash & Short-Term Investments	$ 4.97M	$ 148.89K	$ 74.37K
Total Assets	$ 11.58M	$ 517.93K	$ 74.37K
Total Debt	$ 346.70K	$ 0.00	$ 0.00
Net Debt	$ -4.63M	$ -148.89K	$ -74.37K
Total Liabilities	$ 361.04K	$ 14.57K	$ 14.28K
Stockholders' Equity	$ 11.22M	$ 503.36K	$ 60.09K
Cash Flow
Free Cash Flow	$ -10.48M	$ -555.58K	$ -120.00
Operating Cash Flow	$ -10.48M	$ -555.58K	$ -120.00
Investing Cash Flow	$ 0.00	$ 0.00	$ 0.00
Financing Cash Flow	$ 15.31M	$ 630.10K	$ 72.06K

Currency in USD

Curanex Pharmaceuticals Inc. Earnings and Revenue History

Income Statement >

Curanex Pharmaceuticals Inc. Debt to Assets

Balance Sheet >

Curanex Pharmaceuticals Inc. Cash Flow

Cash Flow >

Curanex Pharmaceuticals Inc. Forecast EPS vs Actual EPS

Currently, no data available

Please return soon. This page is being updated.

Earnings >